Now showing items 1-19 of 19

      Financiación
      The research and publication of research were supported by the Spanish Society of Orthopedics and Traumatology (SECOT) Foundation. [1]
      This research was supported by the Unidad de Innovación Docente, University of Granada, Spain through grants UGR11-294 and UGR11-303. [1]
      This study was partially supported by grant P11-CTS-7649 and grant CTS-109 from Junta de Andalucía, FEDER funds, a grant from Esteve, and a grant from the Centro para el Desarrollo Tecnológico Industrial (NeoGenius Pharma project). F. R. Nieto was supported by a FPU grant from the Spanish Ministerio de Educación y Ciencia (MEC) and C. M. Cendán by the Research Program of the University of Granada. [1]
      This study was supported by the NanoGSkin project of EuroNanoMed-III (ERA-NET Cofund action of the Horizon 2020 Research and Innovation Framework Programme, EU), and cofunded by the Instituto de Salud Carlos III (ISCIII) through AES 2017 (ref. AC17/00013) and the Centro para el Desarrollo Tecnológico Industrial (CDTI) (ref. 00108589), Spanish Ministry of Science and Innovation. Support was also provided through projects PE-0395-2019 from the Consejería de Salud y Familias, Junta de Andalucía, Spain, and B-CTS-450-UGR20 (proyectos de I+D+i en el marco del Programa Operativo FEDER Andalucía 2014-2020, University of Granada and Consejería de Transformación Económica, Industria, Conocimiento y Universidades). Additional support was from the Spanish Plan Nacional de Investigación Científica, Desarrollo e Innovación Tecnológica (I+D+i) of the Spanish Ministry of Science and Innovation through grants FIS PI20/0317 (ISCIII), FIS PI21/0980 (ISCIII) and RTC-2017-6696-1 (Nanogrow), co-financed by the European Regional Development Fund (ERDF) through the “Una manera de hacer Europa” program. [1]
      This study was supported by the Spanish National Plan for Scientific and Technical Research and Innovation (I + D + I) from the Spanish Ministry of Economy and Competitiveness (Carlos III Institute of Health), grants FIS PI14/0955 and FIS PI17/0391 (both cofinanced by ERDF‐FEDER, European Union); by the Spanish Ministry of Health, Social Policy and Equity, grant EC10‐285; and by preclinical research funds from the Regional Ministry of Health through the Andalusian Initiative for Advanced Therapies. [1]
      This study was supported by the Spanish Plan Nacional de Investigación Científica, Desarrollo e Innovación Tecnológica (I+D+I), Instituto de Salud Carlos III (ISCIII), grant FIS PI11/2680, and by the Regional Ministry of Health, grant SAS PI-0462-2010, Junta de Andalucía Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. [1]
      This work was partially supported by an Instituto de Salud Carlos III Grant (FIS 01/0727). [1]
      This work was partially supported by Award no. AC17/00013 (NanoGSkin) by ISCIII thorough AES 2017 and within the EuroNanoMed framework. [1]
      This work was partially supported by the Ministerio de Educación y Cultura (PB97-0840) and the Agencia Española de Cooperación Internacional (AECI). [1]
      This work was primarily supported by the European Union (LSHG-CT-2006-018739; ESTOOLS). MFF is funded by the Spanish Ramon & Cajal Programme and the Health Department of the Spanish Government (PI061267). The Cancer Epigenetics group at the CNIO is supported by the Health (FIS01-04) and Education and Science (I+D+I MCYT08-03, FU2004-02073/BMC and Consolider MEC09-05) Departments of the Spanish Government, the European Grant TRANSFOG LSHC-CT-2004-503438, and the Spanish Association Against Cancer (AECC). VC is a recipient of a Fellowship from the FPU Spanish Research Programme. CLL and BSA are supported by the Health Department of the Spanish Government (PI051707). The BACM is supported by the Consejería de Salud de la Junta de Andalucía (0029 and, 0030/2006 to PM) and, the Spanish Ministry of Health to PM (FIS PI070026). CB is supported by the International Jose Carreras Foundation against Leukemia (EDThomas-05) and the ISCIII (FIS 3+3 contract). The Institute of Reconstructive Neurobiology received additional funding from the DFG and the Hertie Foundation. BS, AbH and AnH are supported by the Fundación Progreso y Salud and Instituto de Salud Carlos III-Red Española de Terapia Celular (RD06/0010/0025 ). PWA, NH and HDM are also supported by the MRC. [1]
      This work was supported by CTS-115 (Tissue Engineering Group), Junta de Andalucia. [1]
      This work was supported by CTS-115 (Tissue Engineering Group), University of Granada/Spain. [1]
      This work was supported by preclinical research funds from the Regional Government of Andalusia through the Andalusian Initiative for Advanced Therapies [1]
      This work was supported by the grants FIS 03/0141 and FIS 04/1306 from the Spanish National Ministry of Health (Instituto de Salud Carlos III) and by CM 2005/011 from Junta de Andalucía. [1]
      This work was supported by the grants FIS PI08/614 from the Spanish Instituto de Salud Carlos III and SAS PI-0132 from Junta de Andalucía. [1]
      This work was supported by the Health (FIS01-04) (PI061267), Education and Science (I+D+I MCYT08-03, FU2004-02073/BMC and Consolider MEC09-05) Departments of the Spanish Government, the European Grant TRANSFOG LSHC-CT-2004-503438, and the Spanish Association Against Cancer (AECC). M.B. is funded by the Association Against Cancer (AECC). [1]
      This work was supported by the Ministerio de Educación y Cultura through Project PB97-0804, and by the Agencia Española de Cooperación Internacional through Project AEC1/98/01. [1]
      This work was supported by University of Granada-Campus de Excelencia Internacional, Subprograma de I+D+I y Transferencia and by the Spanish Ministry of Economy and Competitiveness, grant IPT-300000-2010-017 (INNPACTO program), co-financed by the European Regional Development Fund, European Union. [1]
      This work was supported by: Career Development Award 2001 (to J. M.) from the American Society of Clinical Oncology (ASCO). The Developmental tumour biology laboratory, Hospital Sant Joan de Déu in Barcelona, is supported by grants from the Spanish Ministry of Health (Redes Temáticas de Investigación Cooperativa 2002;G03/089), the Catalan government (AGAUR, Generalitat de Catalunya, 2005SGR00605), and the generous gift from Fondo Margarita del Pozo to the laboratory. Supported in part by the National Cancer Institute grant CA106450 (NKC and WG), The Robert Steel Foundation (NKC), Hope Street Kids (NKC), and Katie's Find A Cure Fund (NKC). [1]